Page 24 - Robert Drain News Today

___

The family that owns Purdue Pharma had hoped a reformulated version of Oxycontin would help rein in the burgeoning opioid crisis a decade ago, a member of the Sackler family

Purdue Pharmas quest to settle thousands of lawsuits over the toll of OxyContin and its...

Credit Jeff J. Mitchell / New Hampshire Bulletin/Getty Images Fifteen states have reached a deal with Purdue Pharma on the company’s bankruptcy organization plan. New Hampshire is not among them. The deal moves the states and company a step closer to a $4.5 billion opioid settlement. Plaintiffs in the case are trying to hold the company and its owners, the Sackler family, responsible for their role in the opioid crisis. Nationally, more than 500,000 people have died from opioid overdoses caus...

WATERTOWN — An agreement was announced Thursday in the case of Purdue Pharma, manufacturer o… The state could receive up to $200 million in a historic settlement, if approved, that would require the Sackler family to pay $4.5 billion and permanently shutter disgraced OxyContin company Purdue Pharma for its role in fueling the opioid epidemic that killed hundreds of thousands of Americans over the past two decades. Members of the Sackler family have agreed to pay more than $4 billion of t...

Originally published on June 3, 2021 1:41 pm After more than a year of high-stakes negotiations with billions of dollars on the line, a bankruptcy plan for Purdue Pharma, the maker of OxyContin, cleared a major hurdle late Wednesday. Federal Judge Robert Drain in White Plains, N.Y., moved the controversial deal forward despite objections from dozens of state attorneys general, setting the stage for a final vote by the companys creditors expected this summer. The drugmaker filed for Chapter 11 ...

A controversial bankruptcy plan involving Purdue Pharma, which would shield the Sackler family from litigation tied to the opioid crisis, has moved forward.

A controversial bankruptcy plan involving Purdue Pharma, which would shield the Sackler family from litigation tied to the opioid crisis, has moved forward.

Pureradiancephoto/iStock (NEW YORK) — A controversial bankruptcy plan involving OxyContin maker Purdue Pharma, which would shield the Sackler family from litigation tied to the opioid crisis, moved forward Thursday. A federal bankruptcy court judge in White Plains, New York, allowed Purdue to begin soliciting support for its Chapter 11 reorganization plan, which would dissolve the drug company and reestablish it as a public trust. Over 600,000 claimants will now start to receive ballots regar...

With voting set to start soon on OxyContin maker Purdue Pharma’s settlement plan,...